DGAP-DD: WILEX AG english

Notification concerning transactions by persons performing managerial
responsibilities pursuant to section 15a of the WpHG

Directors' Dealings notification transmitted by DGAP - a company of EquityStory AG.
The person with duty of notification is solely responsible for the content
of this announcement.
---------------------------------------------------------------------------

Details of the person subject to the disclosure requirement
Company: dievini Hopp BioTech holding GmbH & Co. KG

Person performing managerial responsibilities, triggering the disclosure requirement for the legal person
Details of the person performing managerial responsibilities
Position: Member of an administrative or supervisory body

Information about the transaction with duty of notification

Description of the financial instrument: Bearer shares of common stock
ISIN/WKN of the financial instrument: DE0006614720
Type of transaction: Subscription
Date: 30.01.2012
Price: 3.10
Currency: EUR
No. of items: 168337
Total amount traded: 521844.70
Place: Ausserbörslich / OTC

Explanation for publication:

Correction of the announcement as of 6 February 2012 (date)
dievini Hopp BioTech holding GmbH & Co. KG's oversubscription of the new
shares from the rights issue is attributed to both corporate bodies, Prof.
Dr. Friedrich von Bohlen und Halbach and Prof. Dr. Christof Hettich.

Information about the company with duty of publication

Issuer: WILEX AG
Grillparzerstr. 10
81675 München
Deutschland
ISIN: DE0006614720
WKN: 661472


End of Directors' Dealings Notification 
(c) DGAP 07.02.2012

DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

ID 14804